今年是我国经济体制改革继续朝着社会主义市场经济过渡的第二年,又是关键性的一年。新年伊始国家推出了一系列财税、金融、外贸、外汇等重大改革举措,影响各行各业的经济活动都相应地发生了变化;药品市场并不例外,也发生了一些令人迷茫的变化,需要重新探讨认识。首先,回顾去年药品市场概况,社会医疗需求持续兴旺,医药工业生产发展较快,进出口贸易相当活跃;但是市场秩序混乱失控、渠道泛滥、药价动荡、竞争加剧、医药商业困难重重、购销增速放慢、经营效益滑坡等。 This year is the second year of the transition of China’s economic system reform towards the socialist market economy. It is also a crucial year. At the beginning of the new year, the country launched a series of major reform measures such as fiscal, taxation, finance, foreign trade, and foreign exchange. The economic activities that have affected all walks of life have changed accordingly; the pharmaceutical market is no exception, and some confusing changes have also taken place. Revisit understanding. First, reviewing the pharmaceutical market situation in the past year, the demand for social and medical services continued to thrive. The pharmaceutical industry experienced rapid growth in production and the import and export trade was quite active. However, the chaotic order in the market led to out-of-control, flooded channels, turbulent drug prices, increased competition, difficulties in pharmaceutical business, and increased purchases and sales. Slow down, operating profit decline and so on.